semaglutide phase 2 (#wegovy/#ozempic) has better results, thus far, in its 3 fatty liver trial than its previous phase trial it seems. 72-week data presented at The Liver Meeting 2024: American Association Compounded Semaglutide 2 Month Program

Some of the most common side effects in clinical trials included nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain

Raux-Deery, M.J

Its also compatible with conventional medications and supplements, though your BHRC physician will review all current treatments to design an integrated protocol optimized for your metabolic goals and health objectives

Form: Lyophilized peptide Purity: 99% Origin: Manufactured and tested in the USA Certifications: Certificate of Analysis (COA) included with every order Mechanism of Action (MOA) Retatrutide acts as a potent tri-agonist for: GLP-1 Receptor: Enhances glucose-dependent insulin secretion and reduces appetite GIP Receptor: Supports insulin release and improves insulin sensitivity Glucagon Receptor: Increases energy expenditure and lipid metabolism The combination of these actions promotes enhanced satiety, improved glycemic profiles, and sustained energy utilization, making it an advanced candidate for metabolic research

When in doubt, consult a doctor or another healthcare provider

Pair a protein-rich food with something high in fiber